Related Experiment Videos
Protein C pathway in sepsis
1Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, 825 NE 13th Street, Oklahoma City, OK 73104, USA. Charles-Esmon@omrf.ouhsc.edu
Annals of Medicine
|January 30, 2003
Summary
The protein C pathway regulates blood clotting and inflammation. Activated protein C (APC) prevents thrombosis and sepsis by inhibiting clotting factors and inflammatory cytokines, with platelets influencing its effectiveness.
Area of Science:
- Biochemistry
- Hematology
- Immunology
Background:
- The protein C pathway is crucial for controlling microvascular coagulation and inflammation.
- Activated protein C (APC) acts as an antithrombotic by inactivating factors Va and VIIIa.
- Platelets can influence APC's antithrombotic activity by protecting factor Va.
Purpose of the Study:
- To review the biology of the protein C pathway.
- To highlight its role in controlling microvascular coagulation and inflammation.
- To discuss the mechanisms of APC's anticoagulant and anti-inflammatory effects.
Main Methods:
- Review of existing literature on the protein C pathway.
- Analysis of APC's interactions with clotting factors (Va, VIIIa) and platelets.
- Examination of APC's effects on inflammatory cytokines (TNF-alpha, IL-1beta) and NF-kappaB.
- Evaluation of APC's impact on sepsis outcomes, D-dimer, and IL-6 levels.
Main Results:
- APC effectively prevents microvascular thrombosis by inactivating factors Va and VIIIa.
- Platelet-bound factor Va shows resistance to APC inactivation.
- APC inhibits inflammatory cytokine elaboration by reducing NF-kappaB activity.
- APC reduces mortality in severe sepsis through anticoagulant and anti-inflammatory mechanisms.
Conclusions:
- The protein C pathway is a key regulator of thrombosis and inflammation.
- APC possesses significant antithrombotic and anti-inflammatory properties.
- APC's efficacy in sepsis is linked to its dual anticoagulant and anti-inflammatory actions.